374 related articles for article (PubMed ID: 26337275)
1. Effect of silencing NEK2 on biological behaviors of HepG2 in human hepatoma cells and MAPK signal pathway.
Zhang MX; Xu XM; Zhang P; Han NN; Deng JJ; Yu TT; Gan YY; He XQ; Long ZX
Tumour Biol; 2016 Feb; 37(2):2023-35. PubMed ID: 26337275
[TBL] [Abstract][Full Text] [Related]
2. Silencing of Nek2 suppresses the proliferation, migration and invasion and induces apoptosis of breast cancer cells by regulating ERK/MAPK signaling.
Xing Z; Zhang M; Wang X; Liu J; Liu G; Feng K; Wang X
J Mol Histol; 2021 Aug; 52(4):809-821. PubMed ID: 34009515
[TBL] [Abstract][Full Text] [Related]
3. NEK2 promotes the progression of liver cancer by resisting the cellular senescence.
Lei Q; Xia J; Feng X; Guo J; Li G; Zhou W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 47(2):153-164. PubMed ID: 35545405
[TBL] [Abstract][Full Text] [Related]
4. NIMA related kinase 2 promotes gastric cancer cell proliferation
Fan WD; Chen T; Liu PJ
World J Gastroenterol; 2019 Jun; 25(23):2898-2910. PubMed ID: 31249448
[TBL] [Abstract][Full Text] [Related]
5. The expression and effects the CABYR-c transcript of CABYR gene in hepatocellular carcinoma.
Li H; Fang L; Xiao X; Shen L
Bull Cancer; 2012 Mar; 99(3):E26-33. PubMed ID: 22285430
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of fatty acid synthase (FASN) affects the proliferation and apoptosis of HepG2 hepatoma carcinoma cells via the β-catenin/C-myc signaling pathway.
Zhang W; Huang J; Tang Y; Yang Y; Hu H
Ann Hepatol; 2020; 19(4):411-416. PubMed ID: 32536483
[TBL] [Abstract][Full Text] [Related]
7. PCAT1 promotes the proliferative and migratory potentials of ovarian cancer via targeting NEK2.
Liu XL; Liu HM; Han N; Li FH; Sun F; Fan DM; Xu Q
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8239-8248. PubMed ID: 31646554
[TBL] [Abstract][Full Text] [Related]
8. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
9. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
10. Inducible T-cell co-stimulators regulate the proliferation and invasion of human hepatocellular carcinoma HepG2 cells.
Wei Y; Wang Y; Zang A; Shang Y; Song Z; Wang Z; Wang Y; Yang H
Biol Res; 2018 Jan; 51(1):2. PubMed ID: 29316975
[TBL] [Abstract][Full Text] [Related]
11. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the prostaglandin E receptor EP2 in paeoniflorin-induced human hepatoma cell apoptosis.
Hu S; Sun W; Wei W; Wang D; Jin J; Wu J; Chen J; Wu H; Wang Q
Anticancer Drugs; 2013 Feb; 24(2):140-9. PubMed ID: 23069790
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
Liu XY; Liu SP; Jiang J; Zhang X; Zhang T
Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263
[TBL] [Abstract][Full Text] [Related]
14. Involvement of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance induced by HBx in hepatoma cell line.
Guan J; Chen XP; Zhu H; Luo SF; Cao B; Ding L
World J Gastroenterol; 2004 Dec; 10(23):3522-7. PubMed ID: 15526378
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Klotho suppresses liver cancer progression and induces cell apoptosis by negatively regulating wnt/β-catenin signaling pathway.
Sun H; Gao Y; Lu K; Zhao G; Li X; Li Z; Chang H
World J Surg Oncol; 2015 Oct; 13():307. PubMed ID: 26499380
[TBL] [Abstract][Full Text] [Related]
16. Pentoxifylline induces apoptosis of HepG2 cells by reducing reactive oxygen species production and activating the MAPK signaling.
Wang Y; Dong L; Li J; Luo M; Shang B
Life Sci; 2017 Aug; 183():60-68. PubMed ID: 28583366
[TBL] [Abstract][Full Text] [Related]
17. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
[TBL] [Abstract][Full Text] [Related]
18. [Interferon-induced transmembrane protein 3 knock-down inhibits proliferation and invasion of hepatocellular carcinoma HepG2 cells in vitro].
Wu RS; Wu LQ; Li KH; Li EL; Feng Q; Zhang JL
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Feb; 36(2):244-9. PubMed ID: 26922024
[TBL] [Abstract][Full Text] [Related]
19. Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.
Wang Z; Wei W; Sun CK; Chua MS; So S
Liver Int; 2015 Apr; 35(4):1403-15. PubMed ID: 25098386
[TBL] [Abstract][Full Text] [Related]
20. [The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma].
Xu Q; Cai W; Zhang M; Liu Q; Liu X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):387-92. PubMed ID: 26927562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]